Resistance to Osimertinib to create a Flurry of Activity To Find Out Why in 2018

Roy S. Herbst, MD, PhD of Yale Cancer Center discusses resistance to osimertinib to create a flurry of activity to find out why in 2018. From the 22nd Annual Perspectives in Thoracic Oncology in New Y... Author: thoraciconcology Added: 01/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts